Let’s talk about dementia
Carrying the Torch of Medical Innovation
EFPIA member companies also play an active role in major collaborative projects funded through the Innovative Medicines Initiative (IMI). Together with academic partners, patients, regulators and health technology specialists we look into all facets of the complex Alzheimer Disease challenge: from understanding the diseases, to prevention strategies. More than 15 collaborative projects include AETIONOMY which explored how neurodegenerative diseases are classified and treated; EMIF which tapped into Europe’s wealth of health data to find promising clues for Alzheimer’s research; EPAD which is using adaptive clinical trial design to deliver better results faster and at lower cost, MOPEAD which tests on line tools to identify cognitive problems, or ROADMAP to define patient relevant outcomes and ways to measure them.